Phase 4Recruiting

Effect of Melatonin, Magnesium, Zinc and Vitamin B12 as Additional Treatment Along with Standard Medicines for High Blood Pressure

Efficacy of a Nutraceutical Combination Melatonin, Magnesium, Zinc, Vitamin B12 as Add On Therapy in Moderately Controlled Essential Hypertension A Randomized, Double Blind, Placebo Controlled Trial - NIL

Sponsor
ST Hospitals Private Limited
Enrollment
60 planned
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Interventions
Nutraceutical Combination Melatonin, Magnesium, Zinc, Vitamin B12
Registry
CTRI-2026-09-118443

Full record on the Clinical Trials Registry – IndiaSource: WHO ICTRP, processed October 5, 2026

Primary outcomes

  • To assess reduction in systolic and diastolic blood pressure <br/ > Timepoint: Baseline: Before initiation of study intervention <br/ > End of study: 4 weeks after initiation of study intervention <br/ >

History

  1. Started

  2. Last registry update

  3. Registered